The DMD Hub helps upskill sites by providing training, mentoring and resources to help ensure that the requirements for DMD clinical trials set by industry are met.
The DMD Hub works collaboratively with industry partners, to act as a one-stop-shop, providing advice and support as they set-up and run DMD clinical trials.
We have a flexible approach, evolving and developing additional tools as required, and to provide tailoured support as detailed below:
If you would like any more information about these areas, or about other aspects around setting up DMD trials, please contact DMD Hub Manager, Emma Heslop.
The DMD Hub is always actively collaborating with industry partners interested in running clinical trials in the UK. We have also worked closely with academic principal investigators (PIs) to develop academic-led clinical trials.
We are currently speaking with:
Below you can find the companies we have supported since 2016, and who we are also working with currently:
![]() |
Pfizer Inc |
|
|
Reveragen |
Vamorolone / VBP15 (Phase 2a/2b) |
|
Duchenne UK / Academic / EU collaboration |
|
|
Wave Life Sciences |
|
|
Catabasis Pharmaceuticals |
|
|
Santhera Pharmaceuticals |
|
|
Italfarmaco |
|
|
Sarepta Therapeutics |
MOMENTUM (Phase 2) |
|
PTC Therapeutics |
|
![]() |
Roche | RO7239361 (Phase 2/3) |
![]() |
Summit | Ezutromid (Phase 2) |
|
Academic Collaboration |